Trial Profile
A real world study evaluating utilization of ledipasvir/sofosbuvir and sofosbuvir/velpatasvir therapies in patients with genotype 1 chronic Hepatitis-C
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Jul 2017
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary) ; Sofosbuvir/velpatasvir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 08 Jul 2017 New trial record